Abstral
These highlights do not include all the information needed to use ABSTRAL safely and effectively. See full prescribing information for ABSTRAL. ABSTRAL (fentanyl) sublingual tablets CII Initial U.S. Approval: 1968
f969e2bc-6297-4e29-89d3-a3685a2c7c6b
HUMAN PRESCRIPTION DRUG LABEL
Nov 30, 2014
Galena Biopharma, Inc.
DUNS: 044320456
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fentanyl citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fentanyl citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fentanyl citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fentanyl citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fentanyl citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
fentanyl citrate
Product Details
FDA regulatory identification and product classification information